The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Thompson John Craig since 2011.
The trader's CIK number is 1509643.
At the time of the last reporting, Thompson John Craig was the Chief Commercial Officer of Anthera Pharmaceuticals Inc. (stock ticker symbol ANTH).
Also see all insider trading activities at Anthera Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2011 | TSRX | 133 | $861 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | TTPH | 0 | $0 | 92,499 | $3,960,080 | 92,499 | $1,336,610 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | ANTH | 8,550 | $11,286 | 0 | $0 | 10,400 | $14,892 |
1. Trius Therapeutics Inc (TSRX)
2. Tetraphase Pharmaceuticals Inc (TTPH)
3. Anthera Pharmaceuticals Inc (ANTH)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2011-08-22 | TSRX | Buy | 133 | 6.48 | 861 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-09-08 | TTPH | Option Ex | 10,000 | 14.45 | 144,500 |
| 2015-09-08 | TTPH | Sale | 10,000 | 44.08 | 440,800 |
| 2015-08-05 | TTPH | Option Ex | 10,000 | 14.45 | 144,500 |
| 2015-08-05 | TTPH | Sale | 10,000 | 46.31 | 463,100 |
| 2015-07-06 | TTPH | Option Ex | 10,000 | 14.45 | 144,500 |
| 2015-07-06 | TTPH | Sale | 10,000 | 47.91 | 479,099 |
| 2015-06-15 | TTPH | Option Ex | 10,000 | 14.45 | 144,500 |
| 2015-06-15 | TTPH | Sale | 10,000 | 41.51 | 415,100 |
| 2015-06-08 | TTPH | Option Ex | 22,499 | 14.45 | 325,110 |
| 2015-06-08 | TTPH | Sale | 22,499 | 43.25 | 973,081 |
| 2015-05-15 | TTPH | Option Ex | 30,000 | 14.45 | 433,500 |
| 2015-05-15 | TTPH | Sale | 30,000 | 39.63 | 1,188,900 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-09-20 | ANTH | Buy | 8,550 | 1.32 | 11,286 |
| 2017-09-07 | ANTH | Option Ex | 10,400 | 1.43 | 14,892 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Thompson John Craig (Chief Commercial Officer of Anthera Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.